«

»

Aspirin for Primary Prevention of Cardiovascular Disease Events

by jmiller on November 21, 2012

“The primary literature suggests that aspirin may provide a reduction in CVD events, but the absolute benefit is small and accompanied by an increase in bleeding.  For aspirin to be beneficial for an individual patient, the risk of a future CVD event must be large enough to outweigh the risk of bleeding.  (Pharmacotherapy, Nov) click here  to read full-text.